A model-based approach to assess the exposure-response relationship of Lorenzo's oil in adrenoleukodystrophy

British Journal of Clinical Pharmacology
Mariam A AhmedGerald V Raymond

Abstract

X-linked adrenoleukodystrophy (X-ALD) is a peroxisomal disorder, most commonly affecting boys, associated with increased very long chain fatty acids (C26:0) in all tissues, causing cerebral demyelination and adrenocortical insufficiency. Certain monounsaturated long chain fatty acids including oleic and erucic acids, known as Lorenzo's oil (LO), lower plasma C26:0 levels. The aims of this study were to characterize the effect of LO administration on plasma C26:0 concentrations and to determine whether there is an association between plasma concentrations of erucic acid or C26:0 and the likelihood of developing brain MRI abnormalities in asymptomatic boys. Non-linear mixed effects modelling was performed on 2384 samples collected during an open label single arm trial. The subjects (n = 104) were administered LO daily at ~2-3 mg kg(-1) with a mean follow-up of 4.88 ± 2.76 years. The effect of erucic acid exposure on plasma C26:0 concentrations was characterized by an inhibitory fractional Emax model. A Weibull model was used to characterize the time-to-developing MRI abnormality. The population estimate for the fractional maximum reduction of C26:0 plasma concentrations was 0.76 (bootstrap 95% CI 0.73, 0.793). Our time-to-event a...Continue Reading

References

Sep 1, 1975·Archives of Neurology·H H SchaumburgE P Richardson
Nov 1, 1989·Neurology·W B RizzoJ A Sgro
Mar 31, 1988·Clinica Chimica Acta; International Journal of Clinical Chemistry·E Kaiser, R Kramar
Apr 1, 1996·Biochemical and Molecular Medicine·T S KicklerH Moser
Apr 9, 1999·Computer Methods and Programs in Biomedicine·E N Jonsson, M O Karlsson
Jan 27, 2005·Molecular Genetics and Metabolism·Stephan KempRonald J A Wanders
Apr 1, 2005·Human Molecular Genetics·Muriel AsheuerPatrick Aubourg
Jul 13, 2005·Archives of Neurology·Hugo W MoserAugusto Odone
Mar 10, 2006·Journal of Lipid Research·Mikhail Y Golovko, Eric J Murphy
Mar 8, 2007·Nature Clinical Practice. Neurology·Hugo W MoserGerald V Raymond
May 29, 2007·Annales d'endocrinologie·P Aubourg
Aug 4, 2009·The AAPS Journal·Radojka M Savic, Mats O Karlsson
Jul 16, 2010·Brain Pathology·Johannes BergerSonja Forss-Petter
Feb 9, 2011·The AAPS Journal·Martin BergstrandMats O Karlsson

❮ Previous
Next ❯

Citations

Mar 11, 2018·Journal of Inherited Metabolic Disease·R J T MockingA H Schene
Jul 25, 2019·Journal of Pharmacokinetics and Pharmacodynamics·Mariam A AhmedReena V Kartha

❮ Previous
Next ❯

Related Concepts

Related Feeds

Addison Disease

Addison's disease, also known as primary adrenal insufficiency and hypocortisolism, is a long-term endocrine disorder in which the adrenal glands do not produce enough steroid hormones. Discover the latest research on Addison's disease here.

Adrenoleukodystrophy

Adrenoleukodystrophy (ALD), the most frequent peroxisomal disorder, is an X-linked disorder caused by a defect in the metabolism of long chain fatty acids leading to demyelination, neurodegeneration, and death. Here is the latest research.